Jun-Jian Wang (Junjian Wang)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Benign Prostatic Hyperplasia

Small Cell Lung Cancer

Extracellular Matrix

Radical Prostatectomy

Top Venues

Science advances

Clinical and translational medicine

Cell biology international

This page only lists publications with an associated author ORCID identifier.

Publications

Shaoqiang Guo, Miaomiao Miao, Yufeng Wu, Dongyue Pan, Qinyan Wu, Zhanfang Kang, Jianwen Zeng, Guoping Zhong, Chengfei Liu, Jun-Jian Wang
DHODH inhibition represents a therapeutic strategy and improves abiraterone treatment in castration-resistant prostate cancer. Oncogene 43 (19) (2024)
Shaoqiang Guo, Miaomiao Miao, Yufeng Wu, Dongyue Pan, Qinyan Wu, Zhanfang Kang, Jianwen Zeng, Guoping Zhong, Chengfei Liu, Jun-Jian Wang
DHODH inhibition represents a therapeutic strategy and improves abiraterone treatment in castration-resistant prostate cancer. Oncogene 43 (19) (2024)
Hong Wang, Huizi Sun, Jie Huang, Zhenhua Zhang, Guodi Cai, Chaofan Wang, Kai Xiao, Xiao-Feng Xiong, Jian Zhang, Peiqing Liu, Xiaoyun Lu, Weineng Feng, Jun-Jian Wang
Therapeutic targeting ERRγ suppresses metastasis via extracellular matrix remodeling in small cell lung cancer. EMBO molecular medicine (2024)
Jie Huang, Shi-Ling Zhang, Chao Zhang, Weiye Huang, Zhenhua Zhang, Yu-Qing Chen, Jun-Wei Su, Hong-Hong Yan, Hua-Jun Chen, Jin-Ji Yang, Jun-Jian Wang, Yi-Long Wu
Genotyping of RB1 status identifies two distinct subtypes in EGFR-mutant lung cancers with SCLC transformation. Clinical and translational medicine 14 (5) (2024)
Shaoqiang Guo, Miaomiao Miao, Yufeng Wu, Dongyue Pan, Qinyan Wu, Zhanfang Kang, Jianwen Zeng, Guoping Zhong, Chengfei Liu, Jun-Jian Wang
DHODH inhibition represents a therapeutic strategy and improves abiraterone treatment in castration-resistant prostate cancer. Oncogene (2024)
Jie Huang, Shi-Ling Zhang, Chao Zhang, Weiye Huang, Zhenhua Zhang, Yu-Qing Chen, Jun-Wei Su, Hong-Hong Yan, Hua-Jun Chen, Jin-Ji Yang, Jun-Jian Wang, Yi-Long Wu
Genotyping of RB1 status identifies two distinct subtypes in EGFR-mutant lung cancers with SCLC transformation. Clinical and translational medicine 14 (5) (2024)
Jie Huang, Shi-Ling Zhang, Chao Zhang, Weiye Huang, Zhenhua Zhang, Yu-Qing Chen, Jun-Wei Su, Hong-Hong Yan, Hua-Jun Chen, Jin-Ji Yang, Jun-Jian Wang, Yi-Long Wu
Genotyping of RB1 status identifies two distinct subtypes in EGFR-mutant lung cancers with SCLC transformation. Clinical and translational medicine 14 (5) (2024)
Cheng Zhang, Jiao-Jiao Yu, Chen Yang, Zhen-Long Yuan, Hui Zeng, Jun-Jian Wang, Shuang Shang, Xiao-Xi Lv, Xiao-Tong Liu, Jing Liu, Qi Xue, Bing Cui, Feng-Wei Tan, Fang Hua
Wild-type IDH1 maintains NSCLC stemness and chemoresistance through activation of the serine biosynthetic pathway. Science translational medicine 15 (726) (2023)
Lu Han, Zhiteng Luo, Yingchen Ju, Bingyi Chen, Taotao Zou, Jun-Jian Wang, Jun Xu, Qiong Gu, Xiang-Lei Yang, Paul Schimmel, Huihao Zhou
The binding mode of orphan glycyl-tRNA synthetase with tRNA supports the synthetase classification and reveals large domain movements. Science advances 9 (6) (2023)
Lu Han, Zhiteng Luo, Yingchen Ju, Bingyi Chen, Taotao Zou, Jun-Jian Wang, Jun Xu, Qiong Gu, Xiang-Lei Yang, Paul Schimmel, Huihao Zhou
The binding mode of orphan glycyl-tRNA synthetase with tRNA supports the synthetase classification and reveals large domain movements. Science advances 9 (6) (2023)
Lu Han, Zhiteng Luo, Yingchen Ju, Bingyi Chen, Taotao Zou, Jun-Jian Wang, Jun Xu, Qiong Gu, Xiang-Lei Yang, Paul Schimmel, Huihao Zhou
The binding mode of orphan glycyl-tRNA synthetase with tRNA supports the synthetase classification and reveals large domain movements. Science advances 9 (6) (2023)
Lu Han, Zhiteng Luo, Yingchen Ju, Bingyi Chen, Taotao Zou, Jun-Jian Wang, Jun Xu, Qiong Gu, Xiang-Lei Yang, Paul Schimmel, Huihao Zhou
The binding mode of orphan glycyl-tRNA synthetase with tRNA supports the synthetase classification and reveals large domain movements. Science advances 9 (6) (2023)
Lin Zhong, Bin Yang, Zhenhua Zhang, Jun-Feng Wang, Xiaojuan Wang, Yinfeng Guo, Weifeng Huang, Qianqian Wang, Guodi Cai, Fan Xia, Shengning Zhou, Shuai Ma, Yichu Nie, Jinping Lei, Min Li, Peiqing Liu, Wenbin Deng, Yonghong Liu, Fanghai Han, Jun-Jian Wang
Targeting autophagy peptidase ATG4B with a novel natural product inhibitor Azalomycin F4a for advanced gastric cancer. Cell death & disease 13 (2) (2022)
Xiong Zhang, Zenghong Huang, Jun-Jian Wang, Zhao Ma, Joy Yang, Eva Corey, Christopher P Evans, Ai-Ming Yu, Hong-Wu Chen
Targeting Feedforward Loops Formed by Nuclear Receptor RORγ and Kinase PBK in mCRPC with Hyperactive AR Signaling. Cancers 13 (7) (2021)
Zhenhua Zhang, Yidi Zhang, Chunju Yang, Qianyu Wang, Hong Wang, Yanting Zhang, Wenbin Deng, Yichu Nie, Yonghong Liu, Xiaowei Luo, Jie Huang, Jun-Jian Wang
Antitumor effects of 3-bromoascochlorin on small cell lung cancer via inhibiting MAPK pathway. Cell biology international 45 (11) (2021)
Liushan Chen, Linghao Qin, Chujun Chen, Qiong Hu, Jun-Jian Wang, Juan Shen
Serum exosomes accelerate diabetic wound healing by promoting angiogenesis and ECM formation. Cell biology international 45 (9) (2021)